Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Virax Biolabs Group stock
Learn how to buy Virax Biolabs Group stock in 5 easy steps.
Virax Biolabs Group is a biotechnology business based in the US. Virax Biolabs Group shares (VRAX) are listed on the NASDAQ and all prices are listed in US Dollars. Virax Biolabs Group employs 5 staff and has a trailing 12-month revenue of around $5,760.
How to buy Virax Biolabs Group stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – VRAX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Virax Biolabs Group stock price (NASDAQ: VRAX)Use our graph to track the performance of VRAX stocks over time.
Virax Biolabs Group shares at a glance
|Latest market close||$0.70|
|52-week range||$0.54 - $29.00|
|50-day moving average||$0.79|
|200-day moving average||$2.78|
|Wall St. target price||N/A|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.21|
Buy Virax Biolabs Group stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Virax Biolabs Group stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Virax Biolabs Group price performance over time
Historical closes compared with the close of $0.7012 from 2023-03-24
|1 week (2023-03-17)||0.11%|
|1 month (2023-02-24)||9.22%|
|3 months (2022-12-23)||23.02%|
|6 months (2022-09-26)||-76.93%|
|1 year (2022-03-22)||N/A|
|2 years (2021-03-22)||N/A|
|3 years (2020-03-22)||N/A|
|5 years (2018-03-22)||N/A|
Virax Biolabs Group financials
|Gross profit TTM||$-9,434|
|Return on assets TTM||-61.02%|
|Return on equity TTM||-166.71%|
|Market capitalisation||$9.6 million|
TTM: trailing 12 months
Virax Biolabs Group share dividends
We're not expecting Virax Biolabs Group to pay a dividend over the next 12 months.
Virax Biolabs Group overview
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name, as well as infrared thermometers, pulse oximeters, masks, gloves, and other PPE products. It also distributes nebulizing machines and smart wearable devices that alert employees to help them follow social distance guidelines. In addition, the company operates an online platform that sells ViraxClear and ViraxCare products. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, employees, individual consumers, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021.
Frequently asked questionsWhat percentage of Virax Biolabs Group is owned by insiders or institutions?
Currently 54.772% of Virax Biolabs Group shares are held by insiders and 1.484% by institutions. How many people work for Virax Biolabs Group?
Latest data suggests 5 work at Virax Biolabs Group. When does the fiscal year end for Virax Biolabs Group?
Virax Biolabs Group's fiscal year ends in March. Where is Virax Biolabs Group based?
Virax Biolabs Group's address is: 30 Broadwick Street, London, United Kingdom, W1F 8LX
More guides on Finder
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
How to Buy Gold Stocks
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
Ask an Expert